Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00566995
Title Phase II Study of Vandetanib in Individuals With Kidney Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

kidney cancer

Therapies

Vandetanib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.